Phase I study of gefitinib, irinotecan,
โ
Jeffrey A. Meyerhardt; Jeffrey W. Clark; Jeffrey G. Supko; Joseph P. Eder; Shuji
๐
Article
๐
2007
๐
Springer
๐
English
โ 329 KB